- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05624463
Effect of Modified Endotracheal Intubation Protocol Combined With Early Oral Intake on Postoperative Recovery Quality in Thyroid and Parathyroid Surgery
March 28, 2024 updated by: Peking Union Medical College Hospital
Effect of Modified Endotracheal Intubation Protocol Combined With Early Oral Intake on Postoperative Recovery Quality in Thyroid and Parathyroid Surgery at a Tertiary Hospital in China: A 2x2 Factorial Randomized Controlled Trial Protocol
The purpose of this study is to assess the effect of modified endotracheal intubation procedure combined with early oral intake on postoperative recovery quality of patients, so as to further optimize the ERAS(enhanced recovery after surgery) program for thyroid or parathyroid surgery.
Study Overview
Status
Completed
Conditions
Detailed Description
After being informed about the study and potential risk, all patients giving written informed consent will undergo a screening-period to determine eligibility for study entry.
Before operation, patients will be randomly assigned to conventional intubation process group or modified intubation process group before the operation.
After the operation, patients will enter the PACU(post-anaesthesia care unit) for further observation.
When the anesthesiologists and surgeons agree that patients have no early oral drinking high-risk factors, patients will be randomly assigned to early resumption of oral intake group or late resumption of oral intake group for further observation and evaluation.
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China
- Peking Union Medical College Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥ 18
- American Society of Anesthesiologists (ASA) physical status classification I-II
- Body mass index 18.5-29.9kg/m2
- First operation on operation day
Exclusion Criteria:
- Patients or family members cannot understand the conditions and objectives of this study
- Preoperative patients with acute pharyngitis, hoarseness, cough, dysphagia, and high risk of aspiration
- The surgeons or anesthesiologists point out that the patient is not suitable for early postoperative drinking (such as considering the injury of recurrent laryngeal nerve or lymphatic vessels during the operation)
- Patients who cannot be intubated under visual laryngoscope(such as difficult airway, loose incisors and so on)
- Exclusion criteria of Quality of Recovery-15* (*Quality of Recovery-15 exclusion criteria: 1. Unable to understand words and language; 2. Difficult to cooperate due to mental disorders; 3. History of alcohol or drug abuse; 4. Any serious pre-existing medical condition that can limit the objective evaluation after surgery; 5. Any life-threatening complications; 6. Emergency surgery)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Modified intubation protocol+early resumption of oral intake
Participants receive modified intubation protocol and early resumption of oral intake.
|
1. Turn on the electromyography (EMG) monitor and connect the EMG monitor to the patient as the patient is anesthetized; 2. View the vocal cords with video laryngoscope and intubate the patient with the EMG endotracheal tube; 3. Check the EMG monitor to confirm the correct contact between the electrodes and vocal cords; 4. Adjust the tube to achieve proper and stable contact between the electrodes and vocal cords; 5. Tape the EMG endotracheal tube at the midline and position the patient.
Patients will drink 30-50ml of normal temperature water after Steward scores ≥ 4 at PACU.
If patients swallow successfully and have no significant discomfort symptoms, physicians will guide patients to resume drinking and eating gradually.
|
Other: Modified intubation protocol+delayed resumption of oral intake
Participants receive modified intubation protocol and delayed resumption of oral intake.
|
1. Turn on the electromyography (EMG) monitor and connect the EMG monitor to the patient as the patient is anesthetized; 2. View the vocal cords with video laryngoscope and intubate the patient with the EMG endotracheal tube; 3. Check the EMG monitor to confirm the correct contact between the electrodes and vocal cords; 4. Adjust the tube to achieve proper and stable contact between the electrodes and vocal cords; 5. Tape the EMG endotracheal tube at the midline and position the patient.
Patients will resume drinking water 6h after the operation at ward.
Before patients resume oral drinking, they will be provided 10ml/kg 5% glucose saline intravenously.
|
Other: Conventional intubation protocol+early resumption of oral intake
Participants receive conventional intubation protocol and early resumption of oral intake.
|
Patients will drink 30-50ml of normal temperature water after Steward scores ≥ 4 at PACU.
If patients swallow successfully and have no significant discomfort symptoms, physicians will guide patients to resume drinking and eating gradually.
1. Intubate the patient with the EMG endotracheal tube and note depth; 2. Position patient and verify the position via Glottic Exam or Respiratory Variation; 3. Fix tube position.
|
Other: Conventional intubation protocol+delayed resumption of oral intake
Participants receive conventional intubation protocol and delayed resumption of oral intake.
|
Patients will resume drinking water 6h after the operation at ward.
Before patients resume oral drinking, they will be provided 10ml/kg 5% glucose saline intravenously.
1. Intubate the patient with the EMG endotracheal tube and note depth; 2. Position patient and verify the position via Glottic Exam or Respiratory Variation; 3. Fix tube position.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Recovery-15 score on the first day after surgery
Time Frame: one day
|
Using Quality of Recovery-15 questionnaire to evaluate the quality of perioperative recovery.
Quality of Recovery-15 consists of 15 comprehensive questions, including physical comfort (5 items), psychological support (2 items), physical independence (2 items), emotional state (4 items), and pain (2 items), each item is scored with 0-10 points, 0 represents poor state, 10 represents good state, and the total score is the Quality of Recovery-15 score of the patient.
|
one day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Recovery-15 score on the day of discharge
Time Frame: one day
|
Using Quality of Recovery-15 questionnaire to evaluate the quality of perioperative recovery.
Quality of Recovery-15 consists of 15 comprehensive questions, including physical comfort (5 items), psychological support (2 items), physical independence (2 items), emotional state (4 items), and pain (2 items), each item is scored with 0-10 points, 0 represents poor state, 10 represents good state, and the total score is the Quality of Recovery-15 score of the patient.
|
one day
|
Intubation time
Time Frame: one day
|
Time from the end of pre-oxygenation to the completion of intubation and position setted.
|
one day
|
Endotracheal tube readjustment rate
Time Frame: one day
|
Rate of endotracheal tube readjustment caused by the lose or weakness of monitor signal during the surgery.
|
one day
|
Patient satisfaction
Time Frame: through patient discharge, an average of 2-3 days after surgery
|
Patient satisfaction was assessed based on the postoperative numeric rating scale (NRS) scores, with 0 indicating extreme dissatisfaction and 10 indicating very satisfaction.
|
through patient discharge, an average of 2-3 days after surgery
|
Postoperative pain
Time Frame: one day
|
The patients were given self-evaluation before resuming oral intake and one day after the surgery.
Pharyngeal pain and surgical incision pain were assesed by a visual analogue scale (VAS), with 0 indicating no pain and 10 indicating the worst pain.
|
one day
|
Postoperative patient discomfort
Time Frame: one day
|
The postoperative patient discomfort included the feeling of thirst and hunger.
The patients were given self-evaluation before surgery and before resuming oral intake after surgery.
The discomfort feelings were assesed by a visual analogue scale (VAS), with 0 indicating no discomfort and 10 indicating the worst discomfort.
|
one day
|
Postoperative nausea and vomiting
Time Frame: through patient discharge, an average of 2-3 days after surgery
|
Researchers recorded the occurences and treatments of postoperative nausea and vomiting.
|
through patient discharge, an average of 2-3 days after surgery
|
Gastrointestinal recovery time
Time Frame: through exhaustion after surgery, an average of 1-2 days after surgery
|
The first postoperative exhaustion time recorded was considered as gastrointestinal recovery time.
|
through exhaustion after surgery, an average of 1-2 days after surgery
|
Drainage volume
Time Frame: through removal of drainage tube, an average of 2 days after surgery
|
Total drainage volume after operation.
|
through removal of drainage tube, an average of 2 days after surgery
|
Postoperative hospital stay length
Time Frame: through patient discharge, an average of 2-3 days after surgery
|
Postoperative hospital stay length
|
through patient discharge, an average of 2-3 days after surgery
|
Adverse event
Time Frame: through patient discharge, an average of 2-3 days after surgery
|
The occurrence of adverse events such as severe choking, reintubation, postoperative bleeding.
|
through patient discharge, an average of 2-3 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Le Shen, PhD, Peking Union Medical College Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2023
Primary Completion (Actual)
February 6, 2024
Study Completion (Actual)
February 9, 2024
Study Registration Dates
First Submitted
November 13, 2022
First Submitted That Met QC Criteria
November 20, 2022
First Posted (Actual)
November 22, 2022
Study Record Updates
Last Update Posted (Actual)
April 1, 2024
Last Update Submitted That Met QC Criteria
March 28, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K-2501
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All IPD that underlie results in a publication are to be shared to other researchers.
IPD Sharing Time Frame
Starting 6 months after publication, and ending 24 months after publication.
IPD Sharing Access Criteria
Researchers may apply for IPD after data access proposal was approved by Research Ethics Committee of PUMCH.
IPD can be used for meta-analysis of individual participant data.
Data access proposal should be sent to pumchshenle@163.com, and IPD will be returned to the applicants.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Tumor
-
XU ZhiPeking UniversityUnknownBreast Tumor | Thyroid TumorChina
-
Mahidol UniversityRecruitingHyperparathyroidism | Benign Tumor of ThyroidThailand
-
Peking Union Medical College HospitalNot yet recruiting
-
Nantes University HospitalUnknown
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Chosun University HospitalCompleted
-
Centre Georges Francois LeclercRecruitingPatients With a Thyroid Tumor Who Received Radioactive Iodine TreatmentFrance
-
Second Military Medical UniversityUnknown
-
Chinese PLA General HospitalCompleted
-
Chang Gung Memorial HospitalCompletedThyroid Cancer, Papillary | Thyroid Cancer | Benign Thyroid TumorTaiwan
Clinical Trials on Modified intubation protocol
-
Boston University Charles River CampusUniversity of Kentucky; Harvard School of Public Health (HSPH)RecruitingDepressive Disorder | Anxiety DisordersUnited States
-
Imam Abdulrahman Bin Faisal UniversityActive, not recruitingBirth Weight | Preterm | Feeding Disorder NeonatalSaudi Arabia
-
Sun Yat-sen UniversityRecruitingNon-hodgkin LymphomaChina
-
Sun Yat-sen UniversityCompletedChildhood Non-Hodgkin's Lymphoma
-
Tuğba AtanCompletedCoronary Artery DiseaseTurkey
-
University Hospital, GrenoblePhilips HealthcareNot yet recruitingAcute Hypoxemic Respiratory FailureFrance
-
University of Sao PauloCompletedContracture of Elbow JointBrazil
-
Clalit Health ServicesCompleted
-
University of AlcalaCompletedVascular Diseases | Lipedema | Dermatologic Complication | AssessmentSpain
-
Universidade Cidade de Sao PauloTerminatedPatellar TendinopathyBrazil